1. Home
  2. MVF vs TERN Comparison

MVF vs TERN Comparison

Compare MVF & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MVF
  • TERN
  • Stock Information
  • Founded
  • MVF 1988
  • TERN 2017
  • Country
  • MVF United States
  • TERN United States
  • Employees
  • MVF N/A
  • TERN N/A
  • Industry
  • MVF Investment Bankers/Brokers/Service
  • TERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MVF Finance
  • TERN Health Care
  • Exchange
  • MVF Nasdaq
  • TERN Nasdaq
  • Market Cap
  • MVF 465.2M
  • TERN 382.2M
  • IPO Year
  • MVF N/A
  • TERN 2021
  • Fundamental
  • Price
  • MVF $7.30
  • TERN $4.52
  • Analyst Decision
  • MVF
  • TERN Buy
  • Analyst Count
  • MVF 0
  • TERN 5
  • Target Price
  • MVF N/A
  • TERN $18.30
  • AVG Volume (30 Days)
  • MVF 162.8K
  • TERN 1.9M
  • Earning Date
  • MVF 01-01-0001
  • TERN 03-13-2025
  • Dividend Yield
  • MVF 4.11%
  • TERN N/A
  • EPS Growth
  • MVF N/A
  • TERN N/A
  • EPS
  • MVF N/A
  • TERN N/A
  • Revenue
  • MVF N/A
  • TERN N/A
  • Revenue This Year
  • MVF N/A
  • TERN N/A
  • Revenue Next Year
  • MVF N/A
  • TERN N/A
  • P/E Ratio
  • MVF N/A
  • TERN N/A
  • Revenue Growth
  • MVF N/A
  • TERN N/A
  • 52 Week Low
  • MVF $5.85
  • TERN $4.17
  • 52 Week High
  • MVF $7.19
  • TERN $11.40
  • Technical
  • Relative Strength Index (RSI)
  • MVF 54.99
  • TERN 36.30
  • Support Level
  • MVF $7.11
  • TERN $4.17
  • Resistance Level
  • MVF $7.30
  • TERN $4.75
  • Average True Range (ATR)
  • MVF 0.09
  • TERN 0.29
  • MACD
  • MVF 0.01
  • TERN 0.03
  • Stochastic Oscillator
  • MVF 62.00
  • TERN 27.89

About MVF Blackrock MuniVest Fund Inc.

Blackrock Munivest Fund Inc is an investment management firm. Its investment objective is to provide current income exempt from regular U.S. federal income tax. The company invests in various sectors such as Health; Transportation; Utilities; Education; Tobacco; Housing and others.

About TERN Terns Pharmaceuticals Inc.

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.

Share on Social Networks: